AptarGroup (ATR)
(Delayed Data from NYSE)
$141.22 USD
+0.82 (0.58%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $141.24 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth C Momentum C VGM
Price, Consensus and EPS Surprise
ATR 141.22 +0.82(0.58%)
Will ATR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ATR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ATR
Greif (GEF) Stock Declines 7% in a Month: Factors to Note
5 Stocks to Buy on a Steady Rebound in Manufacturing Activity
ATR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Industrial Products Stocks Lagging AptarGroup (ATR) This Year?
Are Industrial Products Stocks Lagging AptarGroup (ATR) This Year?
Zacks Industry Outlook Highlights Packaging Corporation of America, Amcor, AptarGroup, Sealed Air and Greif
Other News for ATR
RSI Alert: AptarGroup Now Oversold
AptarGroup Larger Than S&P 500 Component Mosaic
Aptar Named One of the World’s Most Sustainable Companies 2024 by TIME
How Is The Market Feeling About AptarGroup?
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), AptarGroup (ATR) and Avidity Biosciences (RNA)